ArticleJournal of experimental & clinical cancer research : CR2022

Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression.

Kun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.